LensGen gains funding for presbyopia technology

Series A funding of $11 million has been released to LensGen Inc. for further development of novel IOL technology intended to address presbyopia, according to a company press release.
A key clinical performance milestone triggered the release of funding as part of a $21 million funding series led by Hoya Group’s corporate investment arm, the release said.
In addition, LensGen, which is developing the “first modular, fluid-optic, curvature changing IOL,” received two broad and comprehensive patents from the U.S. Patent Office protecting its technology, the release said.

Full Story →